Prodia Widyahusada Tbk. vs Kian Santang Muliatama Tbk. — how do they compare? Prodia Widyahusada Tbk. trades at Rp2,390 (market cap 2.24T, 260.1K 24h volume), while Kian Santang Muliatama Tbk. trades at Rp214 (market cap 312.28B, 9.58M 24h volume). The key difference: Prodia Widyahusada Tbk. is far larger — about 7.2× Kian Santang Muliatama Tbk.'s market cap, and Kian Santang Muliatama Tbk. is more actively traded (9.58M versus 260.1K). Which is the better fit depends on your goals.
| PRDA | RGAS | |
|---|---|---|
Market Cap | 2.24T | 312.28B |
Volume | 260.1K | 9.58M |
Lot | 2.6K | 95.8K |
Turnover | 620.8M | 2.04B |
Average Price | 2,386.79 | 213.39 |
Value | 620.8M | 2.04B |
Indicative Equilibrium Price | 2,390 | 214 |
Indicative Equilibrium Volume | 25 | 708 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Widyahusada Tbk (the Company) was established based on the Deed of Notary Sri Rahayu, SH, No. 14 dated February 8, 1988. Clinical Laboratory Prodia was first established in Solo, Central Java, on May 7, 1973 by a few idealists pharmaceutical educational background.
Read more on PRDA →PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →